IMMCELL LIMITED

Immcell Limited is an innovation‑driven Irish company that transforms the power of nature into cutting‑edge, plant‑based solutions for B2B distribution and licensing. By marrying scientific rigour with sustainable sourcing, Immcell serves both the pharmaceutical sector and the food industry, helping partners bring breakthrough technologies to market quickly and responsibly.

The business operates through two specialised arms. Immcell Pharma delivers innovative technology solutions for pharmaceutical manufacturers, while Immcell Nutra focuses on high‑performance, plant‑derived ingredients for food applications. Its flagship products include a first‑to‑market rapeseed protein, the patented B‑NUC™ (Beta Inosine) for enhanced health benefits, and a natural biofilm inhibitor designed to support advanced pharmaceutical formulations.

With a clear commitment to “exceptional immunity‑boosting ingredients” and “groundbreaking pharmaceutical solutions,” Immcell partners with clients to develop, licence and distribute these novel assets, positioning itself as a trusted catalyst for scientific and nutritional innovation.